Pages that link to "Q50519106"
Jump to navigation
Jump to search
The following pages link to Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms (Q50519106):
Displaying 41 items.
- Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide (Q27010580) (← links)
- Real-time monitoring of human blood-brain barrier disruption (Q30359368) (← links)
- Therapeutic strategies to improve drug delivery across the blood-brain barrier (Q30407443) (← links)
- Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors (Q30581024) (← links)
- Recent advances in blood-brain barrier disruption as a CNS delivery strategy (Q31154008) (← links)
- Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study (Q33329329) (← links)
- Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study (Q33337565) (← links)
- Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study (Q33387577) (← links)
- Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications (Q33851310) (← links)
- Selective boron drug delivery to brain tumors for boron neutron capture therapy (Q33933118) (← links)
- Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries (Q33973657) (← links)
- Drug delivery to tumors of the central nervous system (Q34566426) (← links)
- Neoplastic masquerade syndromes (Q34579874) (← links)
- Strategies for increasing drug delivery to the brain: focus on brain lymphoma (Q34585071) (← links)
- Is intra-arterial chemotherapy useful in high-grade gliomas? (Q34969194) (← links)
- Local drug delivery to the brain (Q34971435) (← links)
- Immunotoxin therapy for CNS tumor (Q35210454) (← links)
- Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme (Q35597943) (← links)
- Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. (Q35621091) (← links)
- Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours (Q36150422) (← links)
- Novel drug delivery strategies in neuro-oncology (Q37533661) (← links)
- Strategies for overcoming the blood-brain barrier for the treatment of brain metastases (Q38233077) (← links)
- Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors. (Q39139224) (← links)
- Isolation of drug delivery from drug effect: problems of optimizing drug delivery parameters (Q40305636) (← links)
- Current status and future of relapsed primary central nervous system lymphoma (PCNSL). (Q40586154) (← links)
- Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means (Q40859254) (← links)
- Intra-arterial administration of carboplatin and the blood brain barrier permeabilizing agent, RMP-7: a toxicologic evaluation in swine (Q42544011) (← links)
- Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study (Q43605305) (← links)
- Metastatic lung disease to the central nervous system: in vitro response to chemotherapeutic agents (Q44796372) (← links)
- Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas (Q46825473) (← links)
- Investigational approaches to the treatment of brain tumors in children (Q48288423) (← links)
- Getting Drugs Across Biological Barriers. (Q48331228) (← links)
- Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine (Q48719642) (← links)
- RMP-7 : Potential as an Adjuvant to the Drug Treatment of Brain Tumours (Q48731192) (← links)
- Ototoxicity of carboplatin delivered locally in a monkey brainstem (Q50468239) (← links)
- Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. (Q51421065) (← links)
- Enhanced brain distribution of carboplatin in a primate model after blood-brain barrier disruption using an implantable ultrasound device. (Q51615250) (← links)
- Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruption in the vertebral artery. (Q52537241) (← links)
- Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption. (Q55478733) (← links)
- Enhancing effect of electric stimulation on cytotoxicity of anticancer agents against rat and human glioma cells (Q73544853) (← links)
- Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going (Q89795262) (← links)